Key Healthcare Opportunities for Technology Companies (Wireless in Healthcare 2008-12, High-Tech Patient Monitoring Systems, RFID in Pharma Manufacturing, US EMR Markets, RFID in Healthcare, Electronic Components for Medical Device Markets)

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

• Healthcare Industry

• Wireless Industry

• Wireless in Healthcare

• Definition and Scope of Study

• Application of Wireless Technologies in Healthcare

• Key Wireless Technologies

• Market Overview

• Market for Wireless Technologies in Healthcare

• Competitive Landscape

• Network Infrastructure Providers

• Software Providers

• Medical Device Manufacturers

• Regulatory Environment

• Conclusions and Future Outlook

• First Conclusion

• Second Conclusion

• Third Conclusion

• Fourth Conclusion

• Fifth Conclusion

CHAPTER TWO: INTRODUCTION AND OVERVIEW

• Healthcare Industry

• Worldwide Healthcare Market

• Information Technology (IT) Market in Healthcare

• Trends

• Challenges

• Industry Adoption of Wireless Technologies

• Hospitals

• Number of Hospitals

• Technology Adoption in Hospitals

• The Most Wireless Hospitals

• Physicians

• Number of Physicians

• Technology Adoption by Physicians

• Nursing Homes

• Technology Adoption by Nursing Homes

• Pharmacies

• Technology Adoption by Pharmacies

• Medical and Diagnostic Laboratories

• Technology Adoption by Laboratories

• Life Insurance Carriers

• Technology Adoption by Life/Health Insurance Carriers

• Wireless Industry

• Trends

• Challenges

• Wireless in Healthcare

• US – The Best Market for Wireless Technologies in Healthcare

• Trends

• Challenges

• Definition and Scope of Study

• Electronic Medical Records

• Regulatory Bodies and Societies

• United States Department of Health and Human Services

• Health Insurance Portability and Accountability Act (HIPAA)

• Health Level Seven

• Federal Communication Commission

• Wireless Telecommunications Bureau

• Healthcare Information and Management Systems Society

• Health Industry Business Communications Council

• Industry Initiatives

• Need for Regulation

• Defining the Network Security Policy for Health Organizations

• Planning the Policy

• E-mail Access

• Content Filtering

• Virtual Private Networks

• Implementing the Policy

• Using the Policy

CHAPTER THREE: OPPORTUNITIES FOR WIRELESS APPLICATIONS IN HEALTHCARE

• Introduction

• Key Benefits

• Healthcare Industry Segmentation for Wireless Applications

• Healthcare Service Providers

• Applications of Wireless Technologies for Healthcare Service Providers Segment

• Pharmaceuticals

• Application of Wireless Technologies for the Pharmaceuticals Segment

• Health Plan Providers

• Applications of Wireless Technologies for Health Plan Providers Segment

• Key Application

• Remote Patient Monitoring

• Market Overview

• Clinical Drug Trial

• Market Overview

• E-Prescription

• Market Overview

• Patient/Asset Tracking

• Market Overview

• Pharmaceutical Sales Force

• Market Overview

CHAPTER FOUR: KEY WIRELESS TECHNOLOGIES

• Data Transmission Session

• Wireless Operating Systems, Languages, and Protocol

• Wireless Networking Technologies

• Wireless Personal Area Network – Bluetooth

• Market Overview

• Benefits of Bluetooth in Healthcare

• Applications of Bluetooth in Healthcare

• Issues with Bluetooth Adoption in Healthcare

• Wireless Personal Area Network – RFID

• Market Overview

• Benefits of RFID in Healthcare

• Applications of RFID in Healthcare

• Issues with RFID Adoption in Healthcare

• Wireless Personal Area Network – Zigbee

• Market Overview

• Benefits of Zigbee in Healthcare

• Applications of Zigbee in Healthcare

• Issues with Zigbee Adoption in Healthcare

• Wireless Personal Area Network – UWB

• Market Overview

• Benefits of UWB in Healthcare

• Applications of UWB in Healthcare

• Wireless Local Area Network (WLAN)

• Market Overview

• Benefits of WLAN in Healthcare

• Applications of WLAN in Healthcare

• Issues with WLAN Adoption in Healthcare

• Wireless Metropolitan Area Network (WMAN)

• Market Overview

• Benefits of WMAN in Healthcare

• Applications of WMAN in Healthcare

• Issues with WMAN Adoption in Healthcare

• Wireless Wide Area Network (WWAN)

• Market Overview

• Benefits of WWAN in Healthcare

• Applications of WWAN in Healthcare

• Issues with WWAN Adoption in Healthcare

CHAPTER FIVE: IMPLEMENTING WIRELESS TECHNOLOGIES IN HEALTHCARE

• Wireless Infrastructure for Healthcare

• Planning for Wireless Infrastructure Deployment

• Initiation and Execution of a Wireless Deployment Project

• Cost of Implementation of Infrastructure

• Cases of Wireless Implementation Costs

• Return-on-Investment Period

CHAPTER SIX: MARKET OVERVIEW OF WIRELESS TECHNOLOGIES IN HEALTHCARE

• Market Definition

• Market Size

• The US Wireless Market in Healthcare

• Technology-wise Market Break-out

• WPAN – Bluetooth Market in Healthcare

• WPAN – RFID Market in Healthcare

• WPAN – Zigbee Market in Healthcare

• WPAN – UWB Market in Healthcare

• WLAN Market in Healthcare

• WMAN Market in Healthcare

• WWAN Market in Healthcare

• Technology Adoption

• Drivers and Inhibitors

• Growth Drivers

• Growth Inhibitors

• Emerging Trends

• Emerging Applications

• Nanobots

• Implantable Medical Devices

CHAPTER SEVEN: CASE STUDIES

• George Washington University Hospital – WLAN Implementation

• Requirement for Implementation of Wireless Technologies

• Expected Benefits

• Planning and Implementation

• Cost of Implementation

• Challenges in Implementation

• Memorial Medical Center – WLAN Implementation

• Requirement for Implementation of Wireless Technologies

• Planning and Implementation

• Challenges in Implementation

• Cardinal Health and RFID Implementation

• Implementing RFID

• Benefits

• Smith & Nephew – Sales Force Automation

• Planning and Implementation

• Benefits

• Achieve Healthcare Technologies – e-Prescription

• Requirement for e-Prescription

• Benefits

• Challenges in Implementation

• Bayer Healthcare – e-Drug Trials

• Requirement for e-Drug Trials

• Benefits

• Planning and Implementation

• Island Health Care – Tele-homecare

• Requirement for Tele-homecare

• Benefits

• Wireless Technologies for Patient Recovery – Remote Patient Monitoring

• Requirement for Remote Monitoring

• Telemonitoring Solution

• Results

CHAPTER EIGHT: COMPETITIVE ANALYSIS AND KEY COMPANY PROFILES

• Competitive Landscape

• Segmentation of Players

• Network Infrastructure Providers

• Software Providers

• Medical Device Manufacturers

• Distribution Channel

• Key Company Profiles

• Network Infrastructure Providers

• Cisco Systems, Inc.

• Company Overview

• Performance Review

• Product Portfolio

• Extreme Networks, Inc.

• Company Overview

• Performance Review

• Product Portfolio

• Nortel Networks Corporation

• Company Overview

• Performance Review

• Product Portfolio

• Motorola/Symbol Technologies, Inc.

• Company Overview

• Performance Review

• Product Portfolio

• Software Providers

• Cerner Corporation

• Company Overview

• Performance Review

• Product Portfolio

• Eclipsys Corporation

• Company Overview

• Performance Review

• Product Portfolio

• QuadraMed Corporation

• Company Overview

• Performance Review

• Product Portfolio

• Medical Device Manufacturers

• Datascope Corporation

• Company Overview

• Performance Review

• Product Portfolio

• Philips Healthcare Division

• Company Overview

• Performance Review

• Product Portfolio

• Siemens Medical Solutions

• Company Overview

• Performance Review

• Product Portfolio

CHAPTER NINE: KEY COMPANY CONTACTS

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: Wireless Technologies in Healthcare, 2005-2012

• Figure 1-2: Segmentation of the Supply Side Industry

CHAPTER TWO: INTRODUCTION AND OVERVIEW

• Figure 2-1: Value Chain of the Healthcare Industry

• Figure 2-2: US Healthcare Spending, 2000-2015

• Figure 2-3: Estimated Change in the IT Budget, 2006-2007

• Figure 2-4: Future Outlook of IT related Technologies and Applications Adoption, 2007-2008

• Figure 2-5: The US Population, 1980-2020

• Figure 2-6: Age-wise Population Distribution, 1980-2020

• Figure 2-7: IT Priorities of Healthcare Organizations in the US, 2005-2008

• Table 2-1: Main Types of Customers of Wireless Technology Solutions in Healthcare

• Table 2-2: Some of the Main Interactions between the Customers

• Figure 2-8: Number of Hospitals in the US, 1975-2005

• Figure 2-9: Number of Hospital Mergers in the US, 1999-2004

• Figure 2-10: Adoption of Wireless Technologies by the US Hospitals, 2003-2010

• Table 2-3: Adoption Behavior of Wireless Technologies by the US Hospitals

• Figure 2-11: Wireless Technologies Adoption at Hospital Offices, 2003-2010

• Figure 2-12: Wireless Technologies Adoption at Hospital Rooms, 2003-2010

• Table 2-4: 25 Most Wireless Hospitals in the US

• Table 2-5: Segmentation of Physicians in the US

• Figure 2-13: Number of Nursing Homes, 2000-2005

• Figure 2-14: Number of Pharmacies and Drug Stores, 2000-2005

• Figure 2-15: Number of Medical and Diagnostic Laboratories, 2000-2005

• Figure 2-16: Number of Direct Life Insurance Carriers, 2000-2005

• Figure 2-17: Wireless Technologies Adoption by Health Insurance Carriers, 2004-2008

• Figure 2-18: Value Chain of the Wireless Industry

• Figure 2-19: Wireless Networking Technologies

• Table 2-6: Percent of Office-based Physicians Using EMRs, by Number of Physicians in Practice, 2006

• Figure 2-20: Percent of Office-based Physicians Using EMRs, by Number of Physicians in Practice, 2006

• Table 2-7: Percent of Office-based Physicians Using EMRs, 2001-2006

• Figure 2-21: Percent of Office-based Physicians Using EMRs, by Number of Physicians in Practice, 2006

CHAPTER THREE: MARKETS FOR WIRELESS APPLICATIONS IN HEALTHCARE

• Table 3-1: Key Differences between Wired and Wireless Technologies

• Figure 3-1: Healthcare Industry

• Figure 3-2: Applications of Wireless Technologies for Healthcare Service Providers

• Figure 3-3: US Wireless Technologies Adoption by Health Insurance

• Carriers, 2004-2007 (in Percent)

• Table 3-2: US Market Forecast for Remote Patient Monitoring, 2007-2012

• Figure 3-4: The US Remote Patient Monitoring Market Forecast, 2007-2012

• Table 3-3: Market Forecast for Electronic Clinical Drug Trials, 2007-2012

• Figure 3-5: The Electronic Clinical Drug Trial Market Forecast, 2007-2012

• Table 3-4: Total Prescription Estimates and Forecast, 2004-2008

• Figure 3-6: Total Prescriptions Estimates and Forecast, 2004-2008

• Table 3-5: Market Forecast for RFID Patient/Asset Tracking, 2007-2012

• Figure 3-7: The RFID Patient/Asset Tracking Market Forecast, 2007-2012

• Table 3-6: Total Medical Sales Represenatives in the United States, Estimates and Forecast, 2005-2015

• Figure 3-8: Total Medical Sales Represenatives in the United States, Estimates and Forecast, 2005-2015

CHAPTER FOUR: CHAPTER FOUR: KEY WIRELESS TECHNOLOGIES

• Figure 4-1: Wireless Networking Technologies

• Figure 4-2: Range of Wireless Networking Technologies

• Figure 4-3: Market Estimates and Forecasts for WPAN – Bluetooth in Healthcare, 2005-2012

• Figure 4-4: RFID Infrastructure and Working

• Figure 4-5: Market Estimates and Forecasts for WPAN – RFID in Healthcare, 2005-2012

• Table 4-1: RFID Application in Healthcare

• Figure 4-6: Market Estimates and Forecasts for WPAN – Zigbee in Healthcare, 2005-2012

• Figure 4-7: Market Estimates and Forecasts for WPAN – UWB in Healthcare, 2005-2012

• Table 4-2: Performance Parameters Comparison of WLAN Standards

• Figure 4-8: Market Estimates and Forecasts for WLAN in Healthcare, 2005-2012

• Figure 4-9: Working Process of VoIP

• Figure 4-10: Wireless Metropolitan Area Network Infrastructure

• Figure 4-11: Market Estimates and Forecasts for WMAN in Healthcare, 2005-2012

• Table 4-3: Comparison of WWAN Data Networks

• Figure 4-12: Working Process of Wireless Wide Area Networks

• Figure 4-13: Data Throughput Ranges for Mobile Phone Technologies, 1990-2010 (in Bits per Second)

• Table 4-4: Comparison between WLAN and WWAN

• Figure 4-14: Market Estimates and Forecasts for WWAN in Healthcare, 2005-2012

CHAPTER FIVE: IMPLEMENTING WIRELESS TECHNOLOGIES IN HEALTHCARE

• Figure 5-1: Wireless Infrastructure

• Figure 5-2: Working of a Typical Wireless Network in a Hospital

• Figure 5-3: Planning for Wireless Technologies Implementation in a Healthcare Environment

• Figure 5-4: Recommended Phases for Implementing a Wireless Network in Healthcare Organizations

CHAPTER SIX: MARKET OVERVIEW OF WIRELESS TECHNOLOGIES IN HEALTHCARE

• Figure 6-1: Wireless Networking Technologies

• Table 6-1: U.S. Wireless Healthcare Market, 2005-2007

• Table 6-2: U.S. Forecast for Wireless Healthcare Market, 2008-2012

• Figure 6-2: Market Estimates and Forecasts for Wireless Technologies in Healthcare, 2005-2012

• Figure 6-3: Percentage Break-up of Market Share for Wireless Technologies in Healthcare

• Table 6-3: Market for WPAN – Bluetooth in Healthcare, 2005-2007

• Table 6-4: Market Forecast for WPAN – Bluetooth in Healthcare, 2008-2012

• Figure 6-4: Market Estimates and Forecasts for WPAN – Bluetooth in Healthcare, 2005-2012

• Figure 6-5: Percent Distribution of Wireless Healthcare Technologies for WPAN – Bluetooth in Healthcare, 2007

• Table 6-5: Market for WPAN – RFID in Healthcare, 2005-2007

• Table 6-6: Market Forecast for WPAN – RFID in Healthcare, 2008-2012

• Figure 6-6: Market Estimates and Forecasts for WPAN – RFID in Healthcare, 2005-2012

• Figure 6-7: Percent Distribution of Wireless Healthcare Technologies for WPAN – RFID in Healthcare, 2007

• Table 6-7: Market for WPAN – Zigbee in Healthcare, 2005-2007

• Table 6-8: Market Forecast for WPAN – Zigbee in Healthcare, 2008-2012

• Figure 6-8: Market Estimates and Forecasts for WPAN – Zigbee in Healthcare, 2005-2012

• Figure 6-9: Percent Distribution of Wireless Healthcare Technologies for WPAN – Zigbee in Healthcare, 2007

• Table 6-9: Market for WPAN – UWB in Healthcare, 2005-2007

• Table 6-10: Market Forecast for WPAN – UWB in Healthcare, 2008-2012

• Figure 6-10: Market Estimates and Forecasts for WPAN – UWB in Healthcare, 2005-2012

• Figure 6-11: Percent Distribution of Wireless Healthcare Technologies for WPAN – UWB in Healthcare, 2007

• Table 6-11: Market for WLAN in Healthcare, 2005-2007

• Table 6-12: Market Forecast for WLAN in Healthcare, 2008-2012

• Figure 6-12: Market Estimates and Forecasts for WLAN in Healthcare, 2005-2012

• Figure 6-13: Percent Distribution of Wireless Healthcare Technologies for WLAN in Healthcare, 2007

• Table 6-13: Market for WMAN in Healthcare, 2005-2007

• Table 6-14: Market Forecast for WMAN in Healthcare, 2008-2012

• Figure 6-14: Market Estimates and Forecasts for WMAN in Healthcare, 2005-2012

• Figure 6-15: Percent Distribution of Wireless Healthcare Technologies for WMAN in Healthcare, 2007

• Table 6-15: Market for WWAN in Healthcare, 2005-2007

• Table 6-16: Market Forecast for WWAN in Healthcare, 2008-2012

• Figure 6-16: Market Estimates and Forecasts for WWAN in Healthcare, 2005-2012

• Figure 6-17: Percent Distribution of Wireless Healthcare Technologies for WWAN in Healthcare, 2007

• Table 6-17: Percentage Adoption of Wireless Networking Technologies in the Healthcare Industry in the US

• Figure 6-18: US Healthcare Spending, 2000-2015

• Figure 6-19: Age-wise Population Distribution, 1980-2020

• Figure 6-20: Demand-Supply Gap for Nurses in the US, 2000-2020

• Figure 6-21: Demand-Supply Gap for Specialist Physicians in the US, 2000-2020

• Figure 6-22: Distribution of Fatal Prescribing Errors

• Figure 6-23: Barriers to Implementing IT, 2005-2008

CHAPTER EIGHT: COMPETITIVE ANALYSIS AND KEY COMPANY PROFILES

• Figure 8-1: Segmentation of the Supply Side Industry

• Figure 8-2: Network Infrastructure Providers, Company Comparison, 2007 Revenues

• Table 8-2: Corporate Details of Cisco Systems, Inc

• Figure 8-3: Cisco Systems, Inc. Revenues, 2002-2007

• Figure 8-4: Break-up of Net Sales – Product Wise, 2007

• Table 8-3: Corporate Details of Extreme Networks, Inc.

• Figure 8-5: Extreme Networks, Inc. Revenues, 2002-2007

• Figure 8-6: Break-up of Net Sales by Region, 2006 and 2007

• Table 8-4: Corporate Details of Nortel Networks

• Figure 8-7: Nortel Networks Corporation Revenues, 2001-2007

• Figure 8-8: Break-up of Overall Revenue by Region

• Table 8-5: Corporate Details of Motorola, Inc

• Figure 8-9: Motorola, Inc. Revenues, 2003-2007

• Figure 8-10: Break-up of Net Sales by Region, 2007

• Figure 8-11: Software Providers, Company Comparison, 2007 Revenues

• Table 8-6: Corporate Details of Cerner Corporation

• Figure 8-12: Cerner Corporation Revenues, 2001-2007

• Table 8-7: Corporate Details of Eclipsys Corporation

• Figure 8-13: Eclipsys Corporation Revenues, 2001-2007

• Table 8-8: Corporate Details of QuadraMed Corporation

• Figure 8-14: QuadraMed Corporation Revenues, 2001-2007

• Figure 8-15: Break-up of Net Sales Business Unit, 2007

• Figure 8-16: Medical Device Manufacturers Company Comparison, 2007 Revenues

• Table 8-9: Corporate Details of Datascope Corporation

• Figure 8-17: Datascope Corporation Revenues, 2001-2007

• Figure 8-18: Break-up of Overall Sales Revenue by Product Category, 2007

• Table 8-10: Corporate Details of Philips Healthcare

• Figure 8-19: Medical Systems Sales to Third Parties, 2003-2007

• Figure 8-20: Break-up of Medical Systems Sales by Region, 2007

• Table 8-11: Corporate Details of Siemens Medical Solutions

• Figure 8-21: Break-up of Medical Systems Sales by Region, 2007

HIGH TECH PATIENT MONITORING

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

• Introduction

• Scope and Methodology

• Products

• Issues and Trends

• Size and Growth of the Market

• Leading Competitors

• Forecast

• CHAPTER TWO: INTRODUCTION

• Overview

• Aging of the Population

• New Technologies

• Wireless Technologiies

• Remote Monitoring

• Telemedicine

• Applications to Sort Data by Disease State

• EMR (EHR) Data Transfer Applications and Equipment

• Proven Cost Effectiveness

• Barriers to Use of High-Tech Patient Monitoring Systems

• Forecast

CHAPTER THREE: PRODUCTS

• Overview

• Offerings

• Abbott

• American Medical Development (AMD) Telemedicine Products

• American TeleCare

• Cardiocom

• Carematix

• Cybernet Medical Corporation

• Drager Medical

• GE Healthcare

• Global Media

• Honeywell HomMed

• iMetrikus

• InTouch Health

• LifeWatch Technologies

• MedApps

• Medtronic

• Philips Medical Systems

• Roche

• St. Jude Medical

• Second Opinion Software

• Viterion TeleHealthcare

• Welch Allyn

• WebVMC

• CHAPTER FOUR: ISSUES AND TRENDS

• Introduction

• Issues and Trends Driving the Market

• Aging of the Population

• New Wireless Technologies

• Decreasing Healthcare Resources

• Emphasis on Reducing Hospital Days

• Nursing Shortage

• Cost Effectiveness

• Issues and Trends in Patient Monitoring Technologies

• Audio and Video

• Algorithms to “Sort” Data or Trigger Alarms

• Off-site Access to Data

• Full-service Outsourcing

• Data Management and the Electronic Medical Record

• Turnkey Systems

• Disease Management Kits

• HIPAA

• System Compatibility

• CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST

• Overview

• Disease States

• Asthma

• COPD

• CHF

• CHD

• Diabetes

• Total Market Size and Forecast

• Technologies

• Wireless and Remote Patient Monitors

• Patient Data Processing Applications and Equipment

• Equipment and Applications to Transfer Data to EMRs

• End-User Markets

• Hospitals

• Home Healthcare

• Nursing Homes

• Other

• Disease States

• Asthma

• COPD

• CHF

• CHD

• Diabetes

• Other

• CHAPTER SIX: CORPORATE PROFILES

• Introduction

• Abbott Laboratories, Inc

• GE Healthcare

• Honeywell HomMed LLC

• Medtronic, Inc.

• Philips Medical Systems

• Roche Diagnostics Corporation

• Other Companies (Global Media Group LLC, iMetrikus, Inc, InTouch Health, LifeWatch Technologies, Inc., MedApps, Inc, St. Jude Medical, Inc., Viterion TeleHealthcare LLC, Welch Allyn Inc.)

• APPENDIX A: REGULATORY AUTHORITIES AND ORGANIZATIONS

• APPENDIX B: LIST OF COMPANIES

• LIST OF EXHIBITS

• CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: The U.S. Market for High-Tech Patient Monitoring Systems 2007-2012

• Figure 1-1: The U.S. Market for High-Tech Patient Monitoring Systems 2007-2012

• CHAPTER THREE PRODUCTS

• Table 3-1: Select Patient Monitoring Systems

• Table 3-1: Select Patient Monitoring Systems January 2008

• CHAPTER FOUR: SSUES AND TRENDS

• Table 4-1: Projected Population of the United States, by Age: 2000 to 2050

• Figure 4-1: Population Aged 65 and Over, and 85 and Over 2000 to 2050

• Figure 4-2: Percent of Population Aged 65 and Over, and 85 and Over 2000 to 2050

• Table 4-2: Resident Population Projections: 2007 to 2050, July 1

• Table 4-3: National Health Expenditure Amounts, by Type of Expenditure: Calendar Years 2001-2015

• Table 4-4: Per Capita Healthcare Expenditures, 2001-2015

• Table 4-5: Percent of Office-based Physicians Using EMRs (EHRs), by Number of Physicians in Practice, 2006

• Figure 4-2: Percent of Office-based Physicians Using EMRs, by Number of Physicians in Practice, 2006

• Table 4-6: Percent of Office-based Physicians Using EMRs, 2001-2006

• Figure 4-3: Percent of Office-based Physicians Using EMRs, 2001-2006

• Table 4-7: Percent of Medical Practices Using EMRs, by Selected Years: 2003-2006

• Figure 4-4: Percent of Medical Practices Using EMRs, by Selected Years: 2003-2006

• Table 4-8: Percentage of Office-based Physicians Reporting Fully or Partially Electronic EMR Systems: United States, 2006

• Table 4-8: Use of Electronic Medical Records by Location Characteristics of Office-based Physicians: United States, 2006

• CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST

• Table 5-1: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes 2007 and 2012

• Figure 5-1: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes 2007 and 2012

• Table 5-2: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes Among Americans Aged 65 and Over 2007 and 2012

• Figure 5-2: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes Among Americans Aged 65 and Over 2007 and 2012

• Table 5-3: U.S. Direct and Indirect Morbidity Costs of Asthma, COPD, CHF, CHD and Diabetes 2007

• Figure 5-3: U.S. Direct and Indirect Morbidity Costs of Asthma, COPD, CHF, CHD, and Diabetes 2007

• Figure 5-4: Percent Distribution of U.S. Direct Costs of Asthma, COPD, CHF, CHD, and Diabetes 2007

• Table 5-4: The U.S. Market for High-Tech Patient Monitoring Systems 2007-2012

• Figure 5-5: The U.S. Market for High-Tech Patient Monitoring Systems 2007-2012

• Table 5-5: The U.S. Market for High-Tech Patient Monitoring Systems, by Technology Type 2007-2012

• Figure 5-6: The U.S. Market for High-Tech Patient Monitoring Systems, by Technology Type 2007-2012

• Figure 5-7: The U.S. Market for High-Tech Patient Monitoring Systems, by Technology Type 2007

• Figure 5-8: The U.S. Market for High-Tech Patient Monitoring Systems, by Technology Type 2012

• Table 5-6: The U.S. Market for Wireless and Remote Patient Monitoring Technologies 2007-2012

• Figure 5-9:The U.S. Market for Wireless and Remote Patient Monitoring Technologies 2007-2012

• Table 5-7: The U.S. Market for Patient Data Processing Applications and Equipment 2007-2012

• Figure 5-10: The U.S. Market for Patient Data Processing Applications and Equipment 2007-2012

• Table 5-8: The U.S. Market for EMR Data Transfer Equipment and Applications 2007-2012

• Figure 5-11: The U.S. Market for EMR Data Transfer Applications and Equipment 2007-2012

• Table 5-9: The U.S. Market for High-Tech Patient Monitoring Systems, by End User (Hospitals, Home Healthcare, Nursing Homes, Other) 2007-2012

• Figure 5-12: The U.S. Market for High-Tech Patient Monitoring Systems, by End User Type (Hospitals, Home Healthcare, Nursing Homes, Other) 2007-2012

• Figure 5-13: The U.S. Market for High-Tech Patient Monitoring Systems, by End User Type (Hospitals, Home Healthcare, Nursing Homes, Other) 2012

• Table 5-10: The U.S. Market for High-Tech Patient Monitoring Systems in Hospitals 2007-2012

• Figure 5-13: The U.S. Market for High-Tech Patient Monitoring Systems in Hospitals 2007-2012

• Table 5-11: The U.S. Market for High-Tech Patient Monitoring Systems in Home Healthcare 2007-2012

• Figure 5-14: The U.S. Market for High-Tech Patient Monitoring Systems in Home Healthcare 2007-2012

• Table 5-12: The U.S. Market for High-Tech Patient Monitoring Systems in Nursing Homes 2007-2012

• Figure 5-15: The U.S. Market for High-Tech Patient Monitoring Systems in Nursing Homes 2007-2012

• Table 5-13: The U.S. Market for High-Tech Patient Monitoring Systems in Other End Uses 2007-2012

• Figure 5-16: The U.S. Market for High-Tech Patient Monitoring Systems in Other End Uses 2007-2012

• Table 5-14: The U.S. Market for High-Tech Patient Monitoring Systems, by Disease State 2007-2012 (Asthma, COPD, CHF, CHD, Diabetes, Other)

• Figure 5-17: The U.S. Market for High-Tech Patient Monitoring Systems, by Disease State (Asthma, COPD, CHF, CHD, Diabetes, Other) 2007-2012

• Figure 5-18: The U.S. Market for High-Tech Patient Monitoring Systems, by Disease State (Asthma, COPD, CHF, CHD, Diabetes, Other) 2007

• Figure 5-19: The U.S. Market for High-Tech Patient Monitoring Systems, by Disease State (Asthma, COPD, CHF, CHD, Diabetes, Other) 2012

• Table 5-15: The U.S. Market for New Technologies in Patient Monitoring of Asthma 2007-2012

• Figure 5-20: The U.S. Market for New Technologies in Patient Monitoring of Asthma 2007-2012

• Table 5-16: The U.S. Market for New Technologies in Patient Monitoring of COPD 2007-2012

• Figure 5-20: The U.S. Market for New Technologies in Patient Monitoring of COPD 2007-2012

• Table 5-17: The U.S. Market for New Technologies in Patient Monitoring of CHF 2007-2012

• Figure 5-21: The U.S. Market for Hig- tech Patient Monitoring of CHF 2007-2012

• Table 5-18: The U.S. Market for High- Tech Patient Monitoring of CHD 2007-2012

• Figure 5-22: The U.S. Market for High- Tech Patient Monitoring of CHD 2007-2012

• Table 5-19: The U.S. Market for High-Tech Patient Monitoring of Diabetes 2007-2012

• Figure 5-23: The U.S. Market for High-Tech Patient Monitoring of Diabetes 2007-2012

• Table 5-20: The U.S. Market for High-Tech Patient Monitoring of Other Conditions 2007-2012

• Figure 5-24: The U.S. Market for High-Tech Patient Monitoring of Other Conditions 2007-2012

• CHAPTER SIX: CORPORATE PROFILES

• Table 6-1 Other Companies and Products

• CHAPTER ONE: EXECUTIVE SUMMARY Introduction

• Scope and Methodology

• Size and Growth of the Market

• Customer Segments

• Cost of RFID Deployment

• Industry Initiatives to Promote the Adoption of RFID in Healthcare and Pharmaceuticals

• CHAPTER TWO: INTRODUCTION Basics of RFID Technology

• Configurations of RFID Systems

• Parameters for Distinguishing RFID Systems

• Classification of RFID Systems

• Classification of RFID Systems on the Basis of Performance

• Classification of RFID Systems on the Basis of their Range

• Classification of RFID Systems on the Basis of Auto ID Centre

• Security Aspects and Possible Attacks on RFID Systems RFID Infrastructure

• Key Benefits of RFID in Healthcare

• Applications of RFID in the Pharmaceutical Industry

• Need for RFID in Pharmaceutical Industry

• RFID Benefits for the Pharmaceutical Industry

• RFID Application Areas

• Drivers

• Challenges

• Application of Identification Technologies

• Anti-Counterfeiting Applications for RFID in the Pharmaceutical Supply Chain

• Pfizer’s SupplyScape E-Pedigree System

• Pharmaceutical Company Case Study

• Background

• Solution – Executing the Pilot

• System and Technology

• Future

• Pharmaceutical Distributor Case Study

• Worldwide Implementation of RFID with Pharmaceuticals Jena Hospital

• EU Project

• St. Clair Hospital

• GlaxoSmithKline

• Refrigerated Drug Cabinets

• Partners Develop E-Pedigree Solutions for Pharmaceutical Companies

• Cardinal Health and California’s Drug Pedigree Law

• Faster and More Accurate Shipping Methods

• CHAPTER THREE: ISSUES AND TRENDS Counterfeit Drugs

• Global Counterfeiting

• World Counterfeiting Issues

• World Health Organization (WHO) and Counterfeit Medicines

• Regional Comparisons and Online Counterfeits

• Internet sales

• Improvements to Shipment Accuracy

• Regulatory Compliance

• Electronic Pedigree and the NABP

• Return on Investment (ROI)

• Estimated ROI for Pharmaceutical Industry

• Improved Inventory Control

• Prescription Sample Control and RFID

• Health and Safety Concerns

• Effects on Blood Products

• Clinical Trials

• Uniform Standards

• Developers Answer to Uniform Standards

• Smaller, Faster Chips

• Privacy Concerns

• Signal Transmissions

• Existing Technologies

• CHAPTER FOUR: MARKET ANALYSIS

• Overview

• US Pharmaceutical RFID Market Size and Forecast

• Industry Voices

• Cost of RFID Deployment

• Implementing RFID

• Industry Initiatives to Promote the Adoption of RFID in Healthcare and Pharmaceuticals

• CHAPTER FIVE: IMPLEMENTING AN RFID SYSTEM

• RFID Infrastructure Deployment

• Implementing RFID in the Pharmaceutical Supply Chain

• Scaling from Pilot to Implementation Stage

• Cost of RFID Infrastructure Deployment

• CHAPTER SIX: CORPORATE PROFILES

• Introduction

• Alien Technology

• Blue Vector

• Hewlett-Packard

• International Business Machines (IBM) Corporation

• Intermec, Inc.

• Motorola, Inc.

• SupplyScape

• Tagsys, Inc.

• Toshiba TEC

• Zebra Technologies Corporation

• APPENDIX A: REGULATORY AUTHORITIES AND ORGANIZATIONS

• APPENDIX B: LIST OF COMPANIES

• TABLE OF EXHIBITS

• CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: Market for RFID Applications in the US Pharmaceutical Industry

• Figure 1-1: Market for RFID Applications in the US Pharmaceutical Industry

• Table 1-2: Major RFID Benefits for Users

• CHAPTER TWO: INTRODUCTION

• Figure 2-1: Parameters for Distinguishing RFID Systems

• Table 2-1: Classification of Radio Frequency in Terms of Performance Parameters

• Table 2-2: Applications of RFID with Different Ranges

• Table 2-3: Comparison of Active and Passive RFID in Terms of Different Performance Parameters

• Figure 2-2: Parameters for Classification of RFID Systems

• Table 2-4: Auto ID Centre Classification of RFID Systems

• Table 2-5: Types of Attacks on RFID Systems and their Countermeasures

• Figure 2-3: Classification of RFID Tags

• Figure 2-4: Value Chain of the RFID Industry

• Table 2-6: Select Identification Technologies Compared on Different Parameters

• Table 2-7: Key Differences between Bar Codes and RFID

• Table 2-8: Vertical-wise Application and Benefits of RFID

• Figure 2-6: Classification of Identification Technologies Applications

• Figure 2-7: Example of a Comprehensive Track-and-Trace Process

• CHAPTER THREE: ISSUES AND TRENDS Table 3-1: Counterfeiting Rates by Region

• Table 3-2: NABP Recommendations Regarding Information to Include in an E-Pedigree System

• Table 3-3: Estimated Return on Investment (millions) for the Implementation of RFID – Typical Large Pharmaceutical Manufacturer

• Figure 3-1: Estimated Return on Investment (millions) for the Implementation of RFID – Typical Large Pharmaceutical Manufacturer

• Table 3-4: Estimated Return on Investment (millions) for the Implementation of RFID – Typical Large Pharmaceutical Distributor

• Figure 3-2: Estimated Return on Investment (millions) for the Implementation of RFID – Typical Large Pharmaceutical Distributor ($millions)

• CHAPTER FOUR: MARKET ANALYSIS

• Table 4-1: World RFID Market

• Figure 4-1: Worldwide Market for RFID

• Table 4-2: Market for RFID Applications in the US Pharmaceutical Industry

• Figure 4-2: Market for RFID Applications in the US Pharmaceutical Industry

• Figure 4-3: Composite Figure – Global Market for RFID with Segmented US RFID Market in Healthcare and the US Pharmaceutical RFID Market

• Figure 4-4: Cost of Implementation of RFID (2004 and 2008)

• CHAPTER FIVE: IMPLEMENTING AN RFID SYSTEM

• Table 5-1: Planning and Implementing RFID Systems

• Figure 5-1: RFID Implementation – Time Taken for Various Stages

• Table 5-2: Phase-wise Proposed Deployment of RFID in the Pharmaceutical Supply Chain

• Abundant opportunities are available for manufacturing companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been hard to obtain. Original equipment manufacturers are finding new opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations continually reviewing manufacturing costs and looking to outsourcing for cost efficiency.

• Kalorama’s OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It features an exhaustive three-way market segmentation: It looks at the OEM market revenues by therapeutic area, as well as by segment of device manufacturing. And it also includes revenues by the general device classifications (commodity/non-commodity). This allows those looking at this growing market to get a complete picture of the OEM market.

• In Vol. I, Materials Processing , markets are analyzed by the following therapeutic areas:

• Cardiovascular

• General Surgery

• Imaging

• I.V. Diagnostics

• Ophthalmology

• Orthopedics

• Respiratory

• Neurology

• Urology

• and the following materials processing sectors:

• Material Handling and Packaging Equipment

• Materials, Chemicals and Adhesives

• Metal Fabrication and Metal Injection Molding

• Plastic Extrusions

• Plastic Moldings

• Flow Control and Fluid Transfer

• Fluid Power Components

• Sterilization Processes

• Revenues are also provided for the following general classification of medical devices:

• Commodity

• Non-Commodity

• For each segment, this Kalorama Information study gives current size data and forecasts to 2011, with compound annual growth rates provided for the 2006 to 2011 market period. In addition this exhaustive market analysis, Kalorama Information study reviews Original Equipment Manufacturing Companies (OEMs), and their key capabilities and products, provides an overview of the general medical device market which builds the foundation for O.E.M. potential, and looks at issues and trends in O.E.M. for device manufacturing.

• A truly worldwide study, current revenues and forecasts in all therapeutic areas and material processing sectors are provided for U.S., European, Asian, ROW and Global markets. The following companies are profiled in this report

• Avail Medical Products Incorporated

• Merit Medical Systems Incorporated

• Memry Incorporated

• TFX Medical Incorporated

• Saint-Gobain

• PEC – Polymer Engineering Co.

• B. Braun O.E.M. Division of B. Braun Medical Incorporated

• 3M Health Care

• MRI Medical Incorporated

• ATP Engineered Rubber & Plastics Group Incorporated

• Advanced Polymers Incorporated

• Creganna Medical Devices

• Oberg Industries Inc

• Dupont Medical Packaging

• Gems Sensors & Controls Inc (Parent Company Danaher Corporation)

• Medtech Group Inc

• Smiths Medical plc

• Symmetry Medical Inc

• Synovis International Solutions, Incorporated

• TOLAS Healthcare Packaging Incorporated

• The following future titles will complete the series(10/07):

• Vol. II Electronics and Advanced Systems

• Vol. III: Finished Clinical Products.

• Chapter One: Executive Summary

• 1.1 The Healthcare Industry

• 1.2 Information Technology (IT) Market in Healthcare

• 1.3 Virtual Reality Industry

• 1.4 Virtual Reality Systems

• 1.5 Virtual Reality Market

• 1.5.1 Market Definition

• 1.5.2 Market Overview

• 1.6 Virtual Reality Market in Healthcare

• 1.7 Application of Virtual Reality In Healthcare

• 1.8 Demand-Side Analysis

• 1.9 Regulatory Environment

• 1.10 Conclusions and Future Outlook

Chapter Two: Overview

• 2.1 Healthcare Industry

• 2.1.1 Market Overview

• 2.1.2 Categorization of Healthcare Services

• 2.1.2.1 Healthcare Service Providers

• 2.1.2.2 Healthcare Industry Value Chain

• 2.1.3 Trends

• 2.1.4 Challenges

• 2.2 Information Technology (IT) Market in Healthcare

• 2.3 Virtual Reality Industry

• 2.3.1 Definition

• 2.3.2 Applications

• 2.3.3 Virtual Reality Systems

• 2.3.3.1 Design Processes of VR System

• 2.3.3.2 Classification of VR Systems

• 2.3.3.3 Input Devices

• 2.3.3.4 Feedback

• 2.3.4 Virtual Reality Market

• 2.3.4.1 Overview

• 2.3.4.2 Government Initiatives

• 2.3.5 Analysis of Factors Affecting the Virtual Reality Industry

• 2.3.5.1 Projection Display Systems

• 2.3.5.2 Semiconductor Devices Industry

• 2.3.5.3 Computer Product and Computer Peripherals Industry

• 2.3.6 Trends

• 2.3.6.1 Widespread Use of Internet Provides Affordable Solutions

• 2.3.6.2 Digitization of Medical Records

• 2.3.7 Challenges

• 2.3.7.1 Technology Limitations

• 2.3.7.2 Prohibitive Cost of Systems

• 2.3.7.3 Concerns about Safety and Health

• 2.3.8 Commercialization of VR Systems

Chapter Three: Opportunities for Virtual Reality in Healthcare

• 3.1 Virtual Reality in Health Industry

• 3.1.1 Introduction

• 3.1.1.1 Market Overview

• 3.1.2 Advantages

• 3.1.2.1 Hands-On Training

• 3.1.2.2 Assessment and Certification of Skills

• 3.1.2.3 Training in Newly Discovered Medical Protocols

• 3.1.2.4 Risk-Free Training

• 3.1.2.5 Gaining Confidence in New and Complex Procedures

• 3.1.2.6 Insights into Medical Condition of the Patient

• 3.1.3 Challenges

• 3.1.3.1 Medical Economics

• 3.1.3.2 Legal Implications

• 3.1.3.3 Insufficient Interfaces

• 3.2 Healthcare Industry Segmentation for Virtual Reality Applications

• 3.2.1 Applications of Virtual Reality in Surgery

• 3.2.1.1 Pre-Operative Planning

• 3.2.1.2 Robot-Assisted Surgery

• 3.2.1.3 Minimum Invasive Surgery

• 3.2.1.4 Augmented Reality Surgery

• 3.2.2 Application of Virtual Reality in Rehabilitation and Therapy

• 3.2.2.1 Psychological and Physical Rehabilitation

• 3.2.2.2 Tele-rehabilitation

• 3.2.3 Application of Virtual Reality in Visualization of Medical Data

• 3.2.3.1 Insights into the Medical Condition of a Patient

• 3.2.3.2 Diagnostics

• 3.2.4 Application of Virtual Reality in Education and Training

• 3.2.4.1 Interactive Learning

• 3.2.4.2 Teaching of Anatomy

• 3.2.4.3 Performance Analysis

• 3.2.4.4 Training on Uncommon Emergency Procedures

• 3.2.4.5 Training in Surgery

• 3.3. Opportunities in Virtual Reality Market based on Therapeutic Areas

• 3.3.1 Cardiology

• 3.3.2 Psychology

• 3.3.3 Radiology

• 3.3.4 Oncology

Chapter Four: Demand-Side Analysis

• 4.1 Introduction

• 4.2 Key Customer Segments

• 4.2.1 Department of Defense

• 4.2.1.1 Overview

• 4.2.1.2 The US DoD’s Expenditure on Healthcare

• 4.2.1.3 Virtual Reality Requirement for US DoD

• 4.2.2 Medical Schools

• 4.2.2.1 Shortage of Physicians: Need to Provide Assistance to a Large Number of Professionals

• 4.2.2.2 High Cost of Training

• 4.2.2.3 Lifelong Training in Advanced Technology for Physicians

• 4.2.2.4 Objective Assessment

• 4.2.3 Hospitals

• 4.2.3.1 Shrinking Margins

• 4.2.3.2 Medical Negligence: Third Largest Cause of Deaths in US

• 4.2.4 Manufacturers of Medical Equipment

• 4.2.4.1 Overview

• 4.2.4.2 Challenges Faced by Manufacturers while Introducing New Products

• 4.2.4.3 VR Solutions for the Challenges Faced by Medical Equipment Manufacturers

Chapter Five: Case Studies

• 5.1 CASE STUDY: Virtual Reality in Rehabilitation and Therapy

• 5.1.1 Use of Virtual Reality to Combat Post-Traumatic Stress Disorder (PTSD)

• 5.1.2 Use of Virtual Reality to Facilitate Pain Distraction

• 5.2 CASE STUDY: Virtual Reality in Visualization of Medical Data

• 5.2.1 Use of Virtual Reality for Diagnosis of a Calcified Heart

• 5.3 CASE STUDY: Virtual Reality in Surgery

• 5.3.1 Use of Virtual Reality for Removing Brain Tumors

• 5.4 CASE STUDY: Virtual Reality in Education and Training

• 5.4.1 Use of Virtual Reality for Training Professionals in Laparoscopic Cholecystectomy…..

Chapter Six: Regulatory Environment

• 6.1 Introduction

• 6.2 International Standards Organization

• 6.2.1 ISO 13407:1999 – Human-Centered Design Processes for Interactive Systems

• 6.3 Food and Drug Administration

• 6.4 Health Insurance Portability and Accountability Act

• 6.4.1 Privacy Rule

• 6.4.2 Security Rule

Chapter Seven: Conclusions

• 7.1 First Conclusion

• 7.2 Second Conclusion

• 7.3 Third Conclusion

• 7.4 Fourth Conclusion

• 7.5 Fifth Conclusion

• 7.6 Sixth Conclusion

• 7.7 Seventh Conclusion

• 7.8 Eighth Conclusion

• 7.9 Ninth Conclusion

Chapter Eight: Company ProfileS

• 8.1 Ascension Technology Corporation

• 8.1.1 Key Facts

• 8.1.2 Company Overview

• 8.1.3 Geographical Presence

• 8.1.4 Business Line and Product Portfolio

• 8.1.5 Key Executives

• 8.1.6 Recent Developments

• 8.1.7 Company Strategy

• 8.2 Fifth Dimension

• 8.2.1 Key Facts

• 8.2.2 Company Overview

• 8.2.3 Geographical Presence

• 8.2.4 Business Lines

• 8.2.5 Key Executives

• 8.2.6 Product Portfolio

• 8.2.7 Company Strategy

• 8.3 Immersion Corporation

• 8.3.1 Key Facts

• 8.3.2 Company Overview

• 8.3.3 Geographical Presence and Subsidiaries

• 8.3.4 Business Lines

• 8.3.5 Key Executives

• 8.3.6 Product Portfolio

• 8.3.7 Performance Review

• 8.3.7.1 Revenue Performance

• 8.3.7.2 Performance of Geographic Segments

• 8.3.7.3 Revenues Earned by Immersion Medical, Inc.

• 8.3.8 Recent Developments

• 8.3.9 Company Strategy

• 8.4 Intuitive Surgical, Inc.

• 8.4.1 Key Facts

• 8.4.2 Company Overview

• 8.4.3 Geographical Presence

• 8.4.4 Key Executives

• 8.4.5 Business Lines and Product Portfolio

• 8.4.6 Performance Review

• 8.4.6.1 Revenue Performance

• 8.4.6.2 Performance of Product Segments

• 8.4.7 Recent Developments

• 8.4.7.1 Technology Acquisitions

• 8.4.7.2 Reorganization of Its International Operation

• 8.4.8 Company Strategy

• 8.5 Mechdyne Corporation

• 8.5.1 Key Facts

• 8.5.2 Company Overview

• 8.5.3 Geographical Presence

• 8.5.4 Business Lines and Product Portfolio

• 8.5.5 Key Executives

• 8.5.6 Recent Developments

• 8.5.7 Company Strategy

• 8.6 Medtronic, Inc.

• 8.6.1 Key Facts

• 8.6.2 Company Overview

• 8.6.3 Geographical Presence and Subsidiaries

• 8.6.4 Business Lines

• 8.6.5 Key Executives

• 8.6.6 Product Portfolio

• 8.6.7 Performance Review

• 8.6.7.1 Revenue Performance

• 8.6.7.2 Performance of Geographic Segments

• 8.6.7.3 Performance of Operating Segments

• 8.6.8 Recent Developments

• 8.6.9 Company Strategy

• 8.7 Mentice AB

• 8.7.1 Key Facts

• 8.7.2 Company Overview

• 8.7.3 Geographical Presence

• 8.7.4 Business Lines and Product Portfolio

• 8.7.5 Key Executives

• 8.7.6 Company Strategy

TABLE OF EXHIBITS

Chapter One: Executive Summary

• Figure 1-1: Flow of Processes in a VR System

• Figure 1-2: Worldwide Market Size for All VR Applications (2000-2010)

• Figure 1-3: Virtual Reality Market in US Healthcare Sector (2004-2010)

Chapter Two: Overview

• Figure 2-1: Healthcare vs. Other Sectors in Contribution to US GDP (2006)

• Figure 2-2: US Healthcare Spending (2005-2015)

• Figure 2-3: Market Players in Healthcare Industry

• Figure 2-4: Value Chain of Healthcare Industry

• Figure 2-5: The US Spending on HIT (2002-2008)

• Figure 2-6: Complete VR System

• Figure 2-7: Flow of Processes in VR System

• Figure 2-8: Classification of VR Systems

• Table 2-1: Features of VR Systems

• Figure 2-9: Market Size for VR Applications (2000-2006)

• Figure 2-10: Market Size Forecast for VR Applications (2007-2010)

• Figure 2-11: Break-up of VR Market – By Geography (2006)

• Figure 2-12: Break-up of Global VR Market (2006)

• Table 2-2: Project, Institute, and Funding Provided under ATP (till 2006)

• Figure 2-13: Projector Display Industry – Value of Shipments vs PPI (2003-2006)

• Figure 2-14: Computing Speed of Intel Processors (1994-2006)

• Figure 2-15: Semiconductor Industry – Value of Shipment vs PPI (2002-2006)

• Figure 2-16: Computer Manufacturing Industry – Value of Shipment

• vs PPI (2002-2006)

• Figure 2-17: Commercialization Cycle for Virtual Reality Products

Chapter Three: Opportunities for Virtual Reality in Healthcare

• Figure 3-1: VR Market in US Healthcare Sector (2004-2010)

• Figure 3-2: Break-up of VR Application Areas in US Healthcare Market (2006)

• Table 3-1: Key Conferences Covering VR Industry

• Figure 3-3: Applications of Virtual Reality in Health Industry

• Figure 3-4: Market Size for VR in Surgery (2004-2010)

• Figure 3-5: Application of VR in Surgery

• Figure 3-6: Market for VR in Rehabilitation and Therapy (2004-2010)

• Figure 3-7: Market for VR in Visualization of Medical Data (2004-2010)

• Figure 3-8: Application of Virtual Reality in Education and Training

• Figure 3-9: Market Size for VR in Education and Training (2004-2010)

• Table 3-2: Annual Data: Cost of Illness and Number of Patients

• Figure 3-10: Direct Costs of Cardiovascular Diseases: 2007 (in USD billion)

Chapter Four: Demand-Side Analysis

• Figure 4-1: Break-up of US DoD’s Healthcare Expenditure (2006)

• Figure 4-2: US Department of Defense Expenditure on Health (2003-2007)

• Figure 4-3: Comparative Index: Number of Physicians Present and Required

• per 100,000 US population

• Table 4-1: Number of Doctors in US: Age Distribution

• Figure 4-5: Number of Hospitals in US (1975-2005)

• Table 4-2: Causes of Deaths in Hospitals

• Figure 4-6: Market Supply for Electromedical Equipment in US (2001-2006)

Chapter Five: Case Studies

• Figure 5-1: Patient Pain Ratings with the Use of Morphine

• During Wound Care

• Figure 5-2: Patient Pain Ratings with/without the Use of VR

• during Wound Care

Chapter Eight: Company Profiles

• Table 8-1: Corporate Details of Ascension Technology Corporation

• Table 8-2: Resellers for Ascension Technology

• Table 8-3: Third-Party Devices and Vendors

• Table 8-4: Applications and Procedures

• Table 8-5: Key Executives: Mentice

• Table 8-6: Corporate Details of Fifth Dimension

• Table 8-7: Resellers for Fifth Dimension

• Table 8-8: Key Executives: Fifth Dimension

• Table 8-9: Self-developed Products

• Table 8-10: Hardware Products Distributed – Company and Product

• Table 8-11: Corporate Details of Immersion Corporation

• Table 8-12: Geographical Presence of Immersion Corporation

• Table 8-13: Key Executives of Immersion Corporation

• Table 8-14: Product Portfolio

• Figure 8-1: Annual Revenues of Immersion Corporation (2001-2006)

• Figure 8-2: Revenues Earned by Immersion Corporation in 2006

• Figure 8-3: Annual Revenues of Immersion Medical, Inc. (2002-2006)

• Table 8-15: Corporate Details of Intuitive Surgical, Inc.

• Table 8-16: Key Executives of Intuitive Surgical, Inc.

• Figure 8-4: Intuitive Surgical Revenue Performance (2001-2005)

• Figure 8-5: Intuitive Surgical Revenues by Product Segment (2006)

• Table 8-17: Corporate Details of Mechdyne Corporation

• Table 8-18: Key Executives of Mechdyne

• Table 8-19: Corporate Details of Medtronic, Inc.

• Table 8-20: Geographical Presence of Medtronic, Inc.

• Table 8-21: Key Executives of Medtronic, Inc.

• Table 8-22: Product Portfolio

• Figure 8-6: Revenues of Medtronic, Inc. (2002-2006)

• Figure 8-7: Medtronic, Inc. Revenues by Geography (2006)

• Figure 8-8: Medtronic, Inc. Revenues by Operating Segments (2006)

• Table 8-23: Partners: Medtronic Navigation

• Table 8-24: Corporate Details of Mentice AB

• Table 8-25: Subsidiaries of Mentice

• Table 8-26: Distributors of Mentice

• Table 8-27: Key Executives: Mentice